KUALA LUMPUR (Aug 29): A total of 14.5 million people representing 61.9% of Malaysia's adult population had completed their two-dose Covid-19 vaccination programme as of Saturday, Aug 28.

Meanwhile, 19.24 million representing 82.2% of its adult population had had at least one dose of the vaccine, according to figures provided by the Special Committee for Ensuring Access to Covid-19 Vaccine Supply (JKJAV) today.

In terms of total population, 58.9% in Malaysia had had at least one dose, while 44.4% were fully inoculated.

In the Klang Valley — comprising Selangor, Kuala Lumpur and Putrajaya — 89.5% of the adult population had been fully vaccinated, while 110.7% had had at least one dose (the figure exceeds 100% as official population statistics have yet to account for changes in population since the last census, and undocumented residents; vaccines were also given out to non-residents).

This means 65.5% of the region's overall population had been fully vaccinated, while 81% had had at least one dose.

Based on the breakdown of states and federal territories, Labuan had the highest percentage of fully inoculated adults at 93.2%, followed by Sarawak at 86.6%. Total population-wise, 64.1% in Labuan were fully inoculated, while Sarawak had 62.8%.

The country had administered 33.72 million vaccine doses as of Saturday — up from 33.39 million on Friday — after 336,642 daily doses were given out on Saturday, down slightly from 343,900 doses previously.

Malaysia reported 20,579 new Covid-19 cases today, marginally lower than yesterday's 22,597 cases.

Daily infections, which had remained above the 20,000 mark since Tuesday (Aug 24), touched a new record high of 24,599 cases on Thursday (Aug 26).

Get the latest news @ www.EdgeProp.my

Subscribe to our Telegram channel for the latest stories and updates 

Click here for more property stories

SHARE
RELATED POSTS
  1. Sinovac vaccine efficacy drops to 28% in three to five months — report
  2. Solution Group obtains MoH approval for private sales of CanSino vaccine
  3. MoH: Sinovac, AstraZeneca vaccines get conditional approval for use as booster shots